New funding for target discovery related to SynGAP1-associated non-syndromic intellectual disability
We are excited to be starting a new project on SynGAP thanks to support from Leon & friends e.V.
SynGAP is a protein that reduces the activity of Ras-GTPases, which are important in regulating the ERK group of MAP kinases and synaptic connectivity. Mutations in the SynGAP1-gene can cause a non-syndromic intellectual disability (NSID) disorder that often includes epilepsy. Our project aims to make use of our recently developed high-throughout physiology pipeline to identify RasGEF proteins, the RasGTPase activators, that counteract the neuronal signalling affected by reduced SynGAP levels. These RasGEFs could potentially be druggable targets relevant for drug discovery approaches to treat SynGAP-associated NSID.
Last updated on March 5, 2025
Recent Posts
- Researchers are investigating how snakes lost their limbsSnakes have not always been legless, but have lost their limbs through evolution. Professor Laura Read moreOctober 8, 2026
- Frontiers of Science seminars are starting this weekAutumn 2026 Frontiers of Science seminars start this week. Come for a coffee and sandwich Read moreOctober 5, 2026
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026